Cargando…

Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis

Gait disorders are one of the leading patient complaints at the sub-acute stroke stage (SSS) and a main determinant of disability. Walking speed (WS) is a major vital and functional index, and the Ten-Meter Walk Test is considered the gold standard after stroke. Based on a systematic review of the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Tasseel-Ponche, Sophie, Delafontaine, Arnaud, Godefroy, Olivier, Yelnik, Alain P., Doutrellot, Pierre-Louis, Duchossoy, Charline, Hyra, Marie, Sader, Thibaud, Diouf, Momar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549366/
https://www.ncbi.nlm.nih.gov/pubmed/36226075
http://dx.doi.org/10.3389/fneur.2022.989622
_version_ 1784805653697527808
author Tasseel-Ponche, Sophie
Delafontaine, Arnaud
Godefroy, Olivier
Yelnik, Alain P.
Doutrellot, Pierre-Louis
Duchossoy, Charline
Hyra, Marie
Sader, Thibaud
Diouf, Momar
author_facet Tasseel-Ponche, Sophie
Delafontaine, Arnaud
Godefroy, Olivier
Yelnik, Alain P.
Doutrellot, Pierre-Louis
Duchossoy, Charline
Hyra, Marie
Sader, Thibaud
Diouf, Momar
author_sort Tasseel-Ponche, Sophie
collection PubMed
description Gait disorders are one of the leading patient complaints at the sub-acute stroke stage (SSS) and a main determinant of disability. Walking speed (WS) is a major vital and functional index, and the Ten-Meter Walk Test is considered the gold standard after stroke. Based on a systematic review of the literature, studies published between January 2000 and November 2021 were selected when WS was reported (ten-meter walk test for short distance and/or 6-min walking distance for long distance) within 6 months following a first ischemic and/or hemorrhagic stroke (SSS) in adults prior to receiving specific walking rehabilitation. Following PRISMA guidelines, a meta-analysis was conducted on two kinds of WS: the principal criterion focused on short-distance WS (ten-meter walking test) and the secondary criteria focused on long-distance WS (6-min test) and meta-regressions to study the association of WS with balance, cognitive disorders and autonomy. Nine studies comprising a total of 939 data on post-stroke patients were selected. The weighted average age was 61 years [95% IC [55-67] and males represented 62% ± 2.7 of patients [57-67]. Average short-distance WS was 0.36 ± 0.06 m.s(−1) [95% CI (0.23–0.49)]. Average long-distance WS was 0.46 ± 0.1 m.s(−1) [95% CI (0.26–0.66)]. The funnel plot revealed asymmetry of publication bias and high heterogeneity of the nine studies (I(2) index 98.7% and Q-test p < 0.0001). Meta-regressions of secondary endpoints could not be performed due to a lack of study data. At the SSS, WS would be lower than data in general population published in literature, but above all, lower than the WS required for safe daily autonomy and community ambulation after stroke. WS must be a priority objective of stroke rehabilitation to increase walking function but also for survival, autonomy, social participation and health-related quality of life.
format Online
Article
Text
id pubmed-9549366
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95493662022-10-11 Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis Tasseel-Ponche, Sophie Delafontaine, Arnaud Godefroy, Olivier Yelnik, Alain P. Doutrellot, Pierre-Louis Duchossoy, Charline Hyra, Marie Sader, Thibaud Diouf, Momar Front Neurol Neurology Gait disorders are one of the leading patient complaints at the sub-acute stroke stage (SSS) and a main determinant of disability. Walking speed (WS) is a major vital and functional index, and the Ten-Meter Walk Test is considered the gold standard after stroke. Based on a systematic review of the literature, studies published between January 2000 and November 2021 were selected when WS was reported (ten-meter walk test for short distance and/or 6-min walking distance for long distance) within 6 months following a first ischemic and/or hemorrhagic stroke (SSS) in adults prior to receiving specific walking rehabilitation. Following PRISMA guidelines, a meta-analysis was conducted on two kinds of WS: the principal criterion focused on short-distance WS (ten-meter walking test) and the secondary criteria focused on long-distance WS (6-min test) and meta-regressions to study the association of WS with balance, cognitive disorders and autonomy. Nine studies comprising a total of 939 data on post-stroke patients were selected. The weighted average age was 61 years [95% IC [55-67] and males represented 62% ± 2.7 of patients [57-67]. Average short-distance WS was 0.36 ± 0.06 m.s(−1) [95% CI (0.23–0.49)]. Average long-distance WS was 0.46 ± 0.1 m.s(−1) [95% CI (0.26–0.66)]. The funnel plot revealed asymmetry of publication bias and high heterogeneity of the nine studies (I(2) index 98.7% and Q-test p < 0.0001). Meta-regressions of secondary endpoints could not be performed due to a lack of study data. At the SSS, WS would be lower than data in general population published in literature, but above all, lower than the WS required for safe daily autonomy and community ambulation after stroke. WS must be a priority objective of stroke rehabilitation to increase walking function but also for survival, autonomy, social participation and health-related quality of life. Frontiers Media S.A. 2022-09-26 /pmc/articles/PMC9549366/ /pubmed/36226075 http://dx.doi.org/10.3389/fneur.2022.989622 Text en Copyright © 2022 Tasseel-Ponche, Delafontaine, Godefroy, Yelnik, Doutrellot, Duchossoy, Hyra, Sader and Diouf. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Tasseel-Ponche, Sophie
Delafontaine, Arnaud
Godefroy, Olivier
Yelnik, Alain P.
Doutrellot, Pierre-Louis
Duchossoy, Charline
Hyra, Marie
Sader, Thibaud
Diouf, Momar
Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis
title Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis
title_full Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis
title_fullStr Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis
title_full_unstemmed Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis
title_short Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis
title_sort walking speed at the acute and subacute stroke stage: a descriptive meta-analysis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549366/
https://www.ncbi.nlm.nih.gov/pubmed/36226075
http://dx.doi.org/10.3389/fneur.2022.989622
work_keys_str_mv AT tasseelponchesophie walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis
AT delafontainearnaud walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis
AT godefroyolivier walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis
AT yelnikalainp walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis
AT doutrellotpierrelouis walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis
AT duchossoycharline walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis
AT hyramarie walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis
AT saderthibaud walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis
AT dioufmomar walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis